Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.105 USD | -1.34% |
|
-15.00% | -41.53% |
06/03 | Orgenesis Inc. completed the acquisition of Certain assets of Neurocords LLC for $5.7 million. | CI |
22/01 | Orgenesis Inc. announced that it expects to receive $5 million in funding | CI |
Capitalization | 98.28L 84.81L 79.09L 73.28L 1.35Cr 85Cr 1.52Cr 9.59Cr 3.61Cr 40Cr 3.69Cr 3.61Cr 145.95Cr | P/E ratio 2022 |
-3.29x | P/E ratio 2023 | -0.26x |
---|---|---|---|---|---|
Enterprise value | 3.16Cr 2.73Cr 2.54Cr 2.36Cr 4.35Cr 271.97Cr 4.88Cr 31Cr 12Cr 127.35Cr 12Cr 12Cr 469.46Cr | EV / Sales 2022 |
1.8x | EV / Sales 2023 | 71.2x |
Free-Float |
79.55% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
More press releases
1 day | -1.34% | ||
1 week | -15.00% | ||
Current month | -25.08% | ||
1 month | -39.84% | ||
3 months | -49.54% | ||
6 months | -20.50% | ||
Current year | -41.53% |
1 week | 1 | ![]() | 1.3 |
1 month | 1 | ![]() | 1.81 |
Current year | 1 | ![]() | 5.89 |
1 year | 0.87 | ![]() | 10.8 |
3 years | 0.87 | ![]() | 26.4 |
5 years | 0.87 | ![]() | 83 |
10 years | 0.87 | ![]() | 168 |
Manager | Title | Age | Since |
---|---|---|---|
Sarah Ferber
CTO | Chief Tech/Sci/R&D Officer | 71 | 02/02/2012 |
Vered Caplan
CEO | Chief Executive Officer | 56 | 24/12/2013 |
Victor Miller
DFI | Director of Finance/CFO | 55 | 02/01/2024 |
Director | Title | Age | Since |
---|---|---|---|
Vered Caplan
CHM | Chairman | 56 | 14/08/2014 |
Yaron Adler
BRD | Director/Board Member | 54 | 17/04/2012 |
Ashish Nanda
BRD | Director/Board Member | 59 | 22/02/2017 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0% | 293,477 M€ | +1.27% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.34% | -15.00% | -84.61% | -94.88% | 73.56L | ||
-8.67% | -9.87% | +15.03% | +12.52% | 23TCr | ||
-1.26% | -1.01% | +8.91% | +0.68% | 12TCr | ||
-0.77% | -0.77% | +31.03% | +110.13% | 5.77TCr | ||
+0.07% | +0.54% | -23.75% | -23.84% | 5.11TCr | ||
+0.85% | +6.42% | -9.93% | +43.09% | 4.23TCr | ||
+0.98% | -0.71% | -25.97% | +10.21% | 3.3TCr | ||
+0.41% | -1.35% | -11.31% | +13.03% | 2.44TCr | ||
-0.93% | -2.49% | -1.63% | +8.20% | 2.24TCr | ||
-0.75% | -6.22% | +11.28% | -41.08% | 2.21TCr | ||
Average | -1.16% | -2.26% | -9.09% | +3.81% | 5.97TCr | |
Weighted average by Cap. | -3.62% | -0.27% | +6.21% | +16.48% |
2022 | 2023 | |
---|---|---|
Net sales | 3.6Cr 3.11Cr 2.9Cr 2.69Cr 4.95Cr 309.94Cr 5.56Cr 35Cr 13Cr 145.13Cr 14Cr 13Cr 535Cr | 5L 5L 4L 4L 7L 4.56Cr 8L 51.7L 19.47L 2.14Cr 19.88L 19.47L 7.87Cr |
Net income | -1.49Cr -1.28Cr -1.2Cr -1.11Cr -2.05Cr -128.1Cr -2.3Cr -15Cr -5.47Cr -60Cr -5.58Cr -5.47Cr -221.11Cr | -5.54Cr -4.78Cr -4.46Cr -4.13Cr -7.61Cr -476.3Cr -8.54Cr -54Cr -20Cr -223.02Cr -21Cr -20Cr -822.16Cr |
Net Debt | 1.5Cr 1.29Cr 1.2Cr 1.12Cr 2.06Cr 128.72Cr 2.31Cr 15Cr 5.49Cr 60Cr 5.61Cr 5.5Cr 222.18Cr | 2.18Cr 1.88Cr 1.75Cr 1.62Cr 2.99Cr 187.42Cr 3.36Cr 21Cr 8Cr 88Cr 8.17Cr 8Cr 323.51Cr |
More financial data
* Estimated data
Employees
146
Calendar
Date | Price | Change | Volume |
---|---|---|---|
17/25/17 | 1.105 $ | -1.34% | 1,362 |
16/25/16 | 1.120 $ | -5.88% | 11,980 |
15/25/15 | 1.190 $ | +0.85% | 4,844 |
14/25/14 | 1.180 $ | +10.28% | 7,381 |
11/25/11 | 1.070 $ | -17.69% | 16,314 |
Delayed Quote OTC Markets, July 17, 2025 at 09:03 pm IST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ORGS Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition